The vasorelaxing effect of hydrogen sulfide on isolated rat aortic rings versus pulmonary artery rings

Acta Pharmacologica Sinica

Volumn 32, Issue 4, 2011, Pages 456-464

  Sun, Yan ^a   Tang, Chao Shu ^a,b   Jin, Hong Fang ^a   Du, Jun Bao ^a,b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

3 mercapto pyruvate sulfurtransferase; aortic rings; cystathinonine gamma lyase; cystathionine beta synthase; glibenclamide 5 hydroxydecanoate; hydrogen sulfide; pulmonary rings; vasorelaxation

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; MESSENGER RNA; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MALE; NONHUMAN; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA; BASE SEQUENCE; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN SULFIDE; IMMUNOHISTOCHEMISTRY; MALE; PULMONARY ARTERY; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 79953793807     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.9     Document Type: Article

References (44)

1. Aaronson PI, Robertson TP, Knock GA, Becker S, Lewis TH, Snetkov V, et al. Hypoxic pulmonary vasoconstriction: mechanisms and controversies. J Physiol 2006; 570: 53-8.
2. Gray GA, Webb DJ. The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther 1996; 72: 109-48. (Pubitemid 26423301)
3. Sata M, Fukuda D. Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J Med Invest 2010; 57: 12-25.
4. Lipworth BJ, Dagg KD. Vasoconstrictor effects of angiotensin II on the pulmonary vascular bed. Chest 1994; 105: 1360-4. (Pubitemid 24152588)
5. Olson KR, Dombkowski RA, Russell MJ, Doellman MM, Head SK, Whitfield NL, et al. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. J Exp Biol 2006; 209: 4011-23. (Pubitemid 44769370)
6. Tang C, Li XH, Du JB. Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. Curr Vasc Pharmacol 2006; 4: 17-22. (Pubitemid 46785178)
7. Chen CQ, Xin H, Zhu YZ. Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacol Sin 2007; 28: 1709-16. (Pubitemid 350029318)
8. Bhatia M. Hydrogen sulfide as a vasodilator. IUBMB Life 2005; 57: 603-6. (Pubitemid 41530547)
9. 2S)? Br J Pharmacol 2006; 149: 609-10.
10. Bełtowski J. Hydrogen sulfide as a biologically active mediator in the cardiovascular system. Postepy Hig Med Dosw 2004; 58: 285-91.
11. 2S)-the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59: 4-24. (Pubitemid 46522698)
12. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917-35. (Pubitemid 350042399)
13. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 2009; 146: 623-6.
14. Olson KR, Whitfield NL, Bearden SE, St Leger J, Nilson E, Gao Y, et al. Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism. Am J Physiol Regul Integr Comp Physiol 2010; 298: R51-60.
15. ATP channel opener. EMBO J 2001; 20: 6008-16. (Pubitemid 33049276)
16. 2S as a Physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-90.
17. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001; 88: 2-11.
18. Zhu P, Huang L, Ge X, Yan F, Wu R, Ao Q. Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling. Int J Exp Pathol 2006; 87: 463-74. (Pubitemid 44813865)
19. Chen Y, Wu R, Geng B, Qi YF, Wang PP, Yao WZ, et al. Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma. Cytokine 2009; 45: 117-23.
20. 2S) contractile activity in rat detrusor muscle. Eur J Pharmacol 2005; 509: 171-7. (Pubitemid 40279075)
21. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318: 756-63. (Pubitemid 38624219)
22. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004; 313: 362-8. (Pubitemid 37543594)
23. Su YW, Liang C, Jin HF, Tang XY, Han W, Chai LJ, et al. Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy. Circ J 2009; 73: 741-9
24. Li L, Hsu A, Moore PK. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation - a tale of three gases. Pharmacol Ther 2009; 123: 386-400
25. Wang YF, Shi L, Du JB. Impact of L-arginine on hydrogen sulfide/ cystathionine-γ-lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem Biophys Res Commun 2006; 345: 851-7
26. Yan H, Du JB, Tang CS. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004; 313: 22-7 (Pubitemid 37524019)
27. Mancardi D, Penna C, Merlino A, Del Soldato P, Wink DA, Pagliaro P. Physiological and pharmacological features of the novel gasotransmitter: Hydrogen sulfide. Biochim Biophys Acta 2009; 1787: 864-72.
28. Sun YG, CaoYX, Wang WW, Ma SF, Yao T, Zhu YC. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res 2008; 79: 632-41.
29. Wang YF, Mainali P, Tang CS, Shi L, Zhang CY, Yan H, et al. Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats. Chin Med J 2008; 121: 420-3. (Pubitemid 351565988)
30. Wang Y, Zhao X, Jin H, Wei H, Li W, Bu D, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Aterioscler Thromb Vasc Biol 2009; 29: 173-9.
31. Olson KR, Whitfield NL, Bearden SE, St Leger J, Nilson E, Gao Y, et al. Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism. Am J Physiol Regul Integr Comp Physiol 2010; 298: R51-60.
32. Shaul P, Magness RR, Muntz KH, DeBeltz D, Buja LM. Alpha 1-adrenergic receptors in pulmonary and systemic vascular smooth muscle. Alterations with development and pregnancy. Circ Res 1990; 67: 1193-200. (Pubitemid 20368017)
33. 2S), an endogenous gas with odor of rotten eggs might be a cardiovascular function regulator. Ann Cardiol Angeiol (Paris) 2008; 57: 136-8.
34. Du J, Hui Y, Cheung Y, Bin G, Jiang H, Chen X, et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 2004; 19: 75-80. (Pubitemid 38489034)
35. + channel activation to acetophenone analogues-mediated in vitro pulmonary artery relaxation of rat. Life Sci 2006; 78: 631-9. (Pubitemid 41785770)
36. Fan LH, Tian HY, Wang J, Huo JH, Hu Z, Ma AQ, et al. Downregulation of Kir6.1/SUR2B channels in the obese rat aorta. Nutrition 2009, 25: 359-63.
37. 2S in rat insulin-secreting cells and the underlying mechanisms. J Physiol 2005; 569: 519-31. (Pubitemid 41830119)
38. ATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J Physiol 2006; 575: 627-44. (Pubitemid 44270186)
39. + channel in 24 hour-hypoxic human pulmonary artery smooth muscle cells. Chin Med J 2005; 118: 12-9. (Pubitemid 40124959)
40. ATP channel-dependent vasodilation. J Diabetes Complications 2003; 17: 6-10. (Pubitemid 36293502)
41. ATP channel gating and its regulation. Prog Biophys Mol Biol 2009; 99: 7-19.
42. + channel openers. Pharmacol Ther 2000; 85: 39-53.
43. ATP channels in health and disease. J Mol Cell Cardiol 2005; 38: 937-43. (Pubitemid 40725941)
44. + channels in rat vascular smooth muscles. Biochem Biophys Res Commun 2002; 296: 463-9.